Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Atyr Pharma Inc
(NQ:
LIFE
)
1.600
+0.010 (+0.63%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Atyr Pharma Inc
< Previous
1
2
3
4
Next >
aTyr Pharma Announces First Quarter 2024 Results and Provides Corporate Update
Today 16:00 EDT
From
aTyr Pharma, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
April 09, 2024
Via
Benzinga
aTyr Pharma to Participate in April Investor Conferences
April 01, 2024
From
aTyr Pharma, Inc.
Via
GlobeNewswire
3 Penny Stocks That Could Be Multibaggers in the Making: March Edition
March 26, 2024
Penny stocks are incredibly risky. However, if you can handle the heat, these ideas might be worth your while.
Via
InvestorPlace
Recap: aTyr Pharma Q4 Earnings
March 14, 2024
Via
Benzinga
aTyr Pharma's Earnings Outlook
March 13, 2024
Via
Benzinga
Analyst Expectations for aTyr Pharma's Future
September 21, 2023
Via
Benzinga
The Latest Analyst Ratings for aTyr Pharma
May 23, 2023
Via
Benzinga
LIFE Stock Earnings: aTyr Pharma Misses EPS for Q4 2023
March 14, 2024
LIFE stock results show that aTyr Pharma missed analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
aTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update
March 14, 2024
From
aTyr Pharma, Inc.
Via
GlobeNewswire
Earnings Scheduled For March 14, 2024
March 14, 2024
Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.
Via
Benzinga
aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2023 Financial Results
February 28, 2024
Management to host conference call and webcast on March 14th at 5:00 pm EDT / 2:00 pm PDT
From
aTyr Pharma, Inc.
Via
GlobeNewswire
aTyr Pharma Announces Expanded Access Program (EAP) for EFZO-FIT™ Clinical Trial Participants
February 21, 2024
From
aTyr Pharma, Inc.
Via
GlobeNewswire
The 3 Best Penny Stocks to Buy in February 2024
February 15, 2024
With proposed FED rate cuts incoming, these are the penny stocks that are likely to see a spark into new rallies.
Via
InvestorPlace
aTyr Pharma to Present Posters Highlighting Importance of Neuropilin-2 in Immune Regulation at Keystone Symposia on Myeloid Cell Diversity
January 29, 2024
From
aTyr Pharma, Inc.
Via
GlobeNewswire
aTyr Pharma: Q1 Earnings Insights
May 09, 2023
Via
Benzinga
Where aTyr Pharma Stands With Analysts
March 10, 2023
Via
Benzinga
aTyr Pharma's Earnings: A Preview
March 08, 2023
Via
Benzinga
aTyr Pharma Announces Howard University President Emeritus Dr. Wayne A. I. Frederick as Advisor
January 18, 2024
Dr. Frederick to advise Company on corporate affairs and commercial strategy for efzofitimod in interstitial lung disease (ILD).
From
aTyr Pharma, Inc.
Via
GlobeNewswire
Beat of Life Entertainment's 'Diya Jalao Roshni Lao' Campaign: Lighting Up Lives and Preserving Tradition!
November 13, 2023
The "Diya Jalao Roshni Lao" campaign was initiated by the Beat of Life Entertainment company in 2022. Its aim is to draw people's attention to our culture, the hard work of potters, hope, their lives,...
Via
IssueWire
Topics
Religion
Exposures
Religion
aTyr Pharma to Present at November Investor Conferences
November 01, 2023
From
aTyr Pharma, Inc.
Via
GlobeNewswire
aTyr Pharma Announces Dosing of First Patient in Phase 2 EFZO-CONNECT™ Study of Efzofitimod in Patients with SSc-ILD
October 31, 2023
Multiple centers in the U.S. are open for enrollment
From
aTyr Pharma, Inc.
Via
GlobeNewswire
aTyr Pharma Presents Efzofitimod Data Demonstrating Statistically Significant Improvements in Time to Relapse, FVC and Patient Reported Outcomes
September 11, 2023
From
aTyr Pharma, Inc.
Via
GlobeNewswire
$12M Bet On This Trucking Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
August 02, 2023
The Dow Jones closed higher on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks...
Via
Benzinga
aTyr Pharma's Cash Runway Secured till 2026, Despite Lack of Material Catalysts: Oppenheimer Analyst
July 05, 2023
Oppenheimer has downgraded aTyr Pharma Inc (NASDAQ: LIFE) to Perform from Outperform, citing a few material catalysts in the next few quarters.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 5, 2023
July 05, 2023
Via
Benzinga
7 Growth Stocks That AI Predicts Will Deliver Triple-Digit Returns in 2023
June 28, 2023
Bard AI has consistently outperformed, and it has identified seven growth stocks that it believes will deliver triple-digit returns.
Via
InvestorPlace
3 Stocks and Cryptos With the Highest Potential Returns
May 07, 2023
If you're only worried about upside, these stocks and cryptos have some of the highest possible returns in the market.
Via
InvestorPlace
7 Hot Growth Stocks Poised to Triple in 2023
May 05, 2023
These hot growth stocks to buy can triple in price in 2023, with some holding impressive upside that's much higher.
Via
InvestorPlace
Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank
March 11, 2023
The collapse of SVB Financial Group (NASDAQ: SIVB) could have a ripple effect on the technology and biotech industries, the two largest sectors that had deposits and financial relationships with the...
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.